This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The ATLAST Long-Term Study

This study has been completed.
Information provided by (Responsible Party):
ApniCure, Inc. Identifier:
First received: November 16, 2011
Last updated: November 5, 2012
Last verified: November 2012
The Study is a multi-center, prospective, open label, single-arm, three-month, long-term study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea (OSA). The objective of the study is to monitor long-term use of the Attune Sleep Apnea System.

Condition Intervention Phase
Obstructive Sleep Apnea (OSA) Device: Attune Sleep Apnea System Phase 2 Phase 3

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The ATLAST Long-Term Study. A Multicenter, Prospective, Long-Term Study of the Attune Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)

Resource links provided by NLM:

Further study details as provided by ApniCure, Inc.:

Primary Outcome Measures:
  • Mean number of hours per night of device use over a 3-month period [ Time Frame: Each night's use ]
    Nightly use will be monitored over a 3-month take-home period.

Enrollment: 39
Study Start Date: November 2011
Study Completion Date: October 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment
Subjects that completed the ATLAST Study
Device: Attune Sleep Apnea System
Observation of Attune Sleep Apnea System for use during sleep.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Subject participated in the ATLAST Study, and completed the 28-day take-home period
  • Subject understands the Study protocol and is willing and able to comply with Study requirements and sign the informed consent form.
  • The study physician and investigator believe that study participation is appropriate for the subject.
  • Subject has at least one molar in each of the four quadrants of the mouth (right upper, right lower, left upper, and left lower).

Exclusion Criteria:

  • Female subjects who are pregnant or intend to become pregnant during the study period.
  • Poor nasal patency as evidenced by the inability to breathe through the nose with the mouth closed.
  • Oral cavity infection or any other oral or dental condition or problem that would limit subject use of the Attune Sleep Apnea System
  • History of any OSA surgical treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01476917

United States, Arizona
REM Medical
Phoenix, Arizona, United States, 85037
United States, California
Penninsula Sleep Center (PSC)
Burlingame, California, United States, 94010
SRI International
Menlo Park, California, United States, 94025
United States, Georgia
Sleep Disorders Center of Georgia
Atlanta, Georgia, United States, 30342
United States, South Carolina
Columbia, South Carolina, United States, 29201
United States, Texas
Sleep Medicine Associates of Texas (SMAT)
Dallas, Texas, United States, 75231
Sponsors and Collaborators
ApniCure, Inc.
Principal Investigator: Ian Colrain, PhD Stanford Research Institute (SRI)
  More Information

Responsible Party: ApniCure, Inc. Identifier: NCT01476917     History of Changes
Other Study ID Numbers: 11449
Study First Received: November 16, 2011
Last Updated: November 5, 2012

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases processed this record on August 23, 2017